Renaissance Technologies - GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 17 filers reported holding GAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$154
-27.7%
46,900
-1.5%
0.00%
Q2 2023$213
+13.9%
47,600
+23.0%
0.00%
Q1 2023$187
+79.8%
38,700
+16.6%
0.00%
Q4 2022$104
-99.9%
33,200
-0.6%
0.00%
Q3 2022$109,000
-8.4%
33,400
+0.9%
0.00%
Q2 2022$119,00033,1000.00%
Other shareholders
GAIN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 151,132$807,0001.04%
CM Management, LLC 90,000$489,0000.37%
Greenlight Capital 546,560$2,968,0000.17%
PRELUDE CAPITAL MANAGEMENT, LLC 58,100$315,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 50,000$267,0000.01%
Veritable, L.P. 25,064$136,0000.00%
Banque Cantonale Vaudoise 3,000$16,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 20,056$107,0000.00%
MILLENNIUM MANAGEMENT LLC 15,754$84,0000.00%
MORGAN STANLEY 800$4,0000.00%
View complete list of GAIN THERAPEUTICS INC shareholders